Beneficial autoimmunity links primary biliary cholangitis to the avoidance of cholangiocarcinoma-Reference-Cited by-同舟云学术

Beneficial autoimmunity links primary biliary cholangitis to the avoidance of cholangiocarcinoma

Published:2021-01-01 Issue:1 Volume:10 Page:
ISSN:2162-402X
Container-title:OncoImmunology
language:en
Short-container-title:OncoImmunology

Author:

Pol Jonathan G.¹²^ORCID,Paillet Juliette¹²³^ORCID,Plantureux Céleste¹²³,Kroemer Guido¹²⁴⁵⁶^ORCID

Affiliation:

1. Equipe 11 labellisée par la Ligue Nationale contre le Cancer, Centre de Recherche des Cordeliers, INSERM U1138, Université de Paris, Sorbonne Université, Paris, France

2. Metabolomics and Cell Biology Platforms, Gustave Roussy Cancer Campus, Villejuif, France

3. Faculté de Médecine, Université Paris-Saclay, Kremlin-Bicêtre, France

4. Institut Universitaire de France, Paris, France

5. Pôle de Biologie, Hôpital Européen Georges Pompidou, AP-HP, Paris, France

6. Suzhou Institute for Systems Medicine, Chinese Academy of Medical Sciences, Suzhou, China

Publisher

Informa UK Limited

Subject

Oncology,Immunology,Immunology and Allergy

Link

https://www.tandfonline.com/doi/pdf/10.1080/2162402X.2021.1968595

Reference10 articles.

1. Immunotherapy in Advanced Biliary Tract Cancers

2. Cholangiocarcinoma 2020: the next horizon in mechanisms and management

3. Autoimmunity affecting the biliary tract fuels the immunosurveillance of cholangiocarcinoma

4. CD8+ cytotoxic T cell and FOXP3+ regulatory T cell infiltration in relation to breast cancer survival and molecular subtypes

5. Beneficial autoimmunity improves cancer prognosis

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. IL23R as an indicator of immune infiltration and poor prognosis in intrahepatic cholangiocarcinoma: a bioinformatics analysis;Translational Cancer Research;2023-10

2. Colangitis biliar primaria: caracterización de una cohorte retrospectiva;Hepatología;2022-07-05